182 / 242
182
Chapter 14
Table 4.
Incidents during PSA
Tachycardia
15 (0,1%)
Hypotension
333 (2,8%)
Hypertension
24 (0,2%)
Seizure
1 (0,008%)
Sentinel risk descriptors
SpO
2
<85% >60 s or <70%
61 (0,5%)
Apnea > 60 s
8 (0,07%)
Aspiration
7 (0,06%)
Cardiovascular collapse
2 (0,016%)
Cardiac arrest
2 (0,016%)
Table 5.
Interventions to treat srAE
Minimal risk interventions
No intervention
111 (0.9%)
Additional sedatives
78 (0.7%)
Antiemetics
15 (0.1%)
Antihistamine
4 (0.03%)
Minor risk interventions
Airway repositioning
670 (5.6%)
Tactile stimulation
185 (1.6%)
Additional oxygen
299 (2.5%)
Moderate risk interventions
Bag valve mask-assisted ventilation
120 (1%)
Laryngeal mask airway
4 (0.03%)
Oral/nasal airway
231 (1.9%)
CPAP
7 (0.06%)
Reversal agents
7 (0.06%)
Rapid IV fuids
43 (0.4%)
Anticonvulsant
1 (0.008%)
Sentinel risk interventions
Chest compressions
2 (0.02%)
Tracheal intubation
8 (0.07%)
Neuromuscular block
6 (0.05%)
Epinephrine or phenylephrine
224 (1.9%)
Noradrenaline
26 (0.2%)
Adrenaline
4 (0.03%)
Atropine to treat bradycardia
32 (0.3%)